Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Efficient Delivery of Antiapoptotic Signals from Marrow Stromal Cells to Acute Lymphoblastic Leukemia Cells Is Associated with Differential Expression of Genes Related to the Membrane and to Regulation of Apoptosis and Is Dependent in Part on Gap Junction Function

Craig A. Mullen, MD PhD, Sana Usmani, DO, Leti Nunez, BS, Olena Tkachenko, MD

Blood (2016) 128 (22): 5066.

https://doi.org/10.1182/blood.V128.22.5066.5066

Published: 2016

Journal Articles

Interference with Bone Marrow Stroma Derived Factors CXCL12 and TGFBI Increases Apoptosis in ALL Cells and Enhances Antileukemia Effects of Dexamethasone, Methotrexate, Vincristine and 6-Mercaptopurine

Sana Usmani, DO, Olena Tkachencko, MD, Leti Nunez, Craig A. Mullen, MD PhD

Blood (2015) 126 (23): 4774.

https://doi.org/10.1182/blood.V126.23.4774.4774

Published: 2015

Journal Articles

A Novel Platform For The Identification Of Stromal-Derived Factors That Enhance Acute Lymphoblastic Leukemia Cell Survival In The Context Of Maintenance Chemotherapy

Lauren B Patrick, B.A., Olena Tkachenko, M.D., Urmila Sivagnanalingam, B.A., Craig A. Mullen, MD, PhD

Blood (2013) 122 (21): 3861.

https://doi.org/10.1182/blood.V122.21.3861.3861

Published: 2013

Journal Articles

Leukemia Free Survival Is Associated with Presence of Leukemia Reactive Antibodies In Allogeneic Transplant Recipients

Craig A. Mullen, MD, PhD, Yu-Chiao Hsu, MS, Andrew Campbell, MS, Johan Jansson, Ph.D., Olena Tkachenko, M.D.

Blood (2010) 116 (21): 2534.

https://doi.org/10.1182/blood.V116.21.2534.2534

Published: 2010

Journal Articles

Understanding Provider Barriers to Hydroxyurea Use for Pediatric Sickle Cell Disease

Suzette O. Oyeku, MD, MPH, Nancy S. Green, MD, Farzana Pashankar, MD, Patricia Giardina, MD, Craig A. Mullen, MD, PhD, Catherine Driscoll, MD

Blood (2010) 116 (21): 255.

https://doi.org/10.1182/blood.V116.21.255.255

Published: 2010

Journal Articles

Genetics of HbF and HbF Response to Hydroxyurea In Pediatric Sickle Cell Disease: A Multi-Site Pilot Analysis of Candidate SNP Variants

Nancy S. Green, MD, Katherine Ender, MD, MPH, Farzana Pashankar, MD, Catherine Driscoll, MD, Patricia Giardina, MD, Craig A. Mullen, MD, PhD, Lorraine Clark, PhD, Jennifer Crotty, PNP, Mara Burney, RN, MPH, Carolyn Hoppe, MD, Sandra Barral, PhD

Blood (2010) 116 (21): 2641.

https://doi.org/10.1182/blood.V116.21.2641.2641

Published: 2010

Journal Articles

Acute Lymphoblastic Leukemia Cells Adapt to Post-Transplant Alloreactivity by Upregulating Sca-1.

Jessica C Shand, MD, Andrew Campbell, BS, Johan Jansson, Craig A. Mullen, MD, PhD

Blood (2008) 112 (11): 1195.

https://doi.org/10.1182/blood.V112.11.1195.1195

Published: 2008

Journal Articles

Pre-B Cell Acute Lymphoblastic Leukemia Cells Carrying a Bcr/Abl Translocation Retain Sensitivity to Minor Histocompatibility Antigen Specific T Cells but Are Resistant to Natural Killer Cells: Implications for Manipulation of Graft Versus Leukemia Effects.

Craig A. Mullen, MD, PhD, Andrew Campbell, MS, Faith Young, MD, Craig T. Jordan, PhD

Blood (2006) 108 (11): 3247.

https://doi.org/10.1182/blood.V108.11.3247.3247

Published: 2006

Journal Articles

Risk Factors for Umbilical Venous Catheter-Associated Thrombosis in Very Low Birth Weight Infants.

Shalu Narang, MD, Jason Roy, PhD, Timothy P. Stevens, MD,MPH, Meggan Butler-O’Hara, RN,MSN, Craig A. Mullen, MD,PhD, Carl T. D’Angio, MD

Blood (2006) 108 (11): 1490.

https://doi.org/10.1182/blood.V108.11.1490.1490

Published: 2006

Journal Articles

Simulataneous Vaccination and Delayed Lymphocyte Infusion for Enhancement of Immune Reactivity Against Acute Lymphoblastic Leukemia or Lymphoma.

Craig A. Mullen, MD, PhD, Olga Sevastianova, MS

Blood (2005) 106 (11): 5248.

https://doi.org/10.1182/blood.V106.11.5248.5248

Published: 2005

Journal Articles

Total Body Irradiation (TBI), Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Pediatric Hematologic Malignancies.

Demetrios Petropoulos, MD, Laura L. Worth, MD, PhD, Craig A. Mullen, MD, PhD, Anita Mahajan, MD, Mary S. Choroszy, APN, Ka Wah Chan, MD

Blood (2004) 104 (11): 1827.

https://doi.org/10.1182/blood.V104.11.1827.1827

Published: 2004

Journal Articles

Augmentation of Post-Transplant Immunity: Antigen Encounter at Time of Hematopoietic Stem Cell Transplantation Enhances Antigen-Specific Donor T Cell Responses in the Post-Transplant Repertoire.

Craig A. Mullen, MD PhD, Ulker Kocak, MD, Joanne L. Shaw, BS, Shahram Mori, PhD

Blood (2004) 104 (11): 2246.

https://doi.org/10.1182/blood.V104.11.2246.2246

Published: 2004

NARROW

Efficient Delivery of Antiapoptotic Signals from Marrow Stromal Cells to Acute Lymphoblastic Leukemia Cells Is Associated with Differential Expression of Genes Related to the Membrane and to Regulation of Apoptosis and Is Dependent in Part on Gap Junction Function

Interference with Bone Marrow Stroma Derived Factors CXCL12 and TGFBI Increases Apoptosis in ALL Cells and Enhances Antileukemia Effects of Dexamethasone, Methotrexate, Vincristine and 6-Mercaptopurine

A Novel Platform For The Identification Of Stromal-Derived Factors That Enhance Acute Lymphoblastic Leukemia Cell Survival In The Context Of Maintenance Chemotherapy

Leukemia Free Survival Is Associated with Presence of Leukemia Reactive Antibodies In Allogeneic Transplant Recipients

Understanding Provider Barriers to Hydroxyurea Use for Pediatric Sickle Cell Disease

Genetics of HbF and HbF Response to Hydroxyurea In Pediatric Sickle Cell Disease: A Multi-Site Pilot Analysis of Candidate SNP Variants

Acute Lymphoblastic Leukemia Cells Adapt to Post-Transplant Alloreactivity by Upregulating Sca-1.

Pre-B Cell Acute Lymphoblastic Leukemia Cells Carrying a Bcr/Abl Translocation Retain Sensitivity to Minor Histocompatibility Antigen Specific T Cells but Are Resistant to Natural Killer Cells: Implications for Manipulation of Graft Versus Leukemia Effects.

Risk Factors for Umbilical Venous Catheter-Associated Thrombosis in Very Low Birth Weight Infants.

Simulataneous Vaccination and Delayed Lymphocyte Infusion for Enhancement of Immune Reactivity Against Acute Lymphoblastic Leukemia or Lymphoma.

Total Body Irradiation (TBI), Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Pediatric Hematologic Malignancies.

Augmentation of Post-Transplant Immunity: Antigen Encounter at Time of Hematopoietic Stem Cell Transplantation Enhances Antigen-Specific Donor T Cell Responses in the Post-Transplant Repertoire.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only